Decentralized Trials Are Here To Stay; What Challenges Do They Face?

Decentralized trials took a leap in popularity over the past few years, in part thanks to the COVID-19 pandemic. In Vivo's sister publication Medtech Insight spoke to two executives at clinical research technology companies about running decentralized clinical trials to discuss the benefits and limitations of trials run remotely.

Decentralized organizations — • Source: Shutterstock

Decentralized clinical trials, which use communication technology to avoid forcing patients to visit a central lab or clinic, are changing how drugs and devices are developed.

They are less burdensome for patients, can reach underserved areas and, if designed well, provide more information to pharmaceutical and...